IPERIONX LTD - ADR (IPX) Fundamental Analysis & Valuation

NASDAQ:IPX • US44916E1001

Current stock price

31.89 USD
+0.77 (+2.47%)
At close:
32.52 USD
+0.63 (+1.98%)
After Hours:

This IPX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IPX Profitability Analysis

1.1 Basic Checks

  • In the past year IPX has reported negative net income.
  • In the past year IPX has reported a negative cash flow from operations.
  • IPX had negative earnings in each of the past 5 years.
  • In the past 5 years IPX always reported negative operating cash flow.
IPX Yearly Net Income VS EBIT VS OCF VS FCFIPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • IPX's Return On Assets of -41.72% is on the low side compared to the rest of the industry. IPX is outperformed by 87.26% of its industry peers.
  • With a Return On Equity value of -49.80%, IPX is not doing good in the industry: 80.25% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -41.72%
ROE -49.8%
ROIC N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
IPX Yearly ROA, ROE, ROICIPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPX Yearly Profit, Operating, Gross MarginsIPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. IPX Health Analysis

2.1 Basic Checks

  • IPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IPX has more shares outstanding than it did 1 year ago.
  • IPX has more shares outstanding than it did 5 years ago.
  • IPX has a worse debt/assets ratio than last year.
IPX Yearly Shares OutstandingIPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IPX Yearly Total Debt VS Total AssetsIPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 27.66 indicates that IPX is not in any danger for bankruptcy at the moment.
  • IPX has a better Altman-Z score (27.66) than 84.71% of its industry peers.
  • IPX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.03, IPX is in the better half of the industry, outperforming 66.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 27.66
ROIC/WACCN/A
WACC13.05%
IPX Yearly LT Debt VS Equity VS FCFIPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.03 indicates that IPX has no problem at all paying its short term obligations.
  • IPX has a better Current ratio (4.03) than 72.61% of its industry peers.
  • IPX has a Quick Ratio of 4.00. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
  • IPX has a Quick ratio of 4.00. This is in the better half of the industry: IPX outperforms 74.52% of its industry peers.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4
IPX Yearly Current Assets VS Current LiabilitesIPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IPX Growth Analysis

3.1 Past

  • The earnings per share for IPX have decreased strongly by -44.24% in the last year.
  • Looking at the last year, IPX shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
  • The Revenue has been growing by 78.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-44.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-100%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%-100%

3.2 Future

  • IPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.53% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-24.18%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y60.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPX Yearly Revenue VS EstimatesIPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
IPX Yearly EPS VS EstimatesIPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. IPX Valuation Analysis

4.1 Price/Earnings Ratio

  • IPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPX Price Earnings VS Forward Price EarningsIPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPX Per share dataIPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IPX's earnings are expected to grow with 31.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.54%
EPS Next 3Y31.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IPX Dividend Analysis

5.1 Amount

  • IPX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IPX Fundamentals: All Metrics, Ratios and Statistics

IPERIONX LTD - ADR

NASDAQ:IPX (4/10/2026, 5:10:37 PM)

After market: 32.52 +0.63 (+1.98%)

31.89

+0.77 (+2.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-17
Earnings (Next)N/A
Inst Owners50.01%
Inst Owner Change0%
Ins Owners16.03%
Ins Owner Change30.32%
Market Cap1.07B
Revenue(TTM)N/A
Net Income(TTM)-53.88M
Analysts80
Price Target46.41 (45.53%)
Short Float %2.31%
Short Ratio2.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)27.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-28.48%
EPS NY rev (3m)-57.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9.91
P/tB 11.26
EV/EBITDA N/A
EPS(TTM)-1.64
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-1.68
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS0
BVpS3.22
TBVpS2.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -41.72%
ROE -49.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4
Altman-Z 27.66
F-Score2
WACC13.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)909.1%
Cap/Sales(5y)2901.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-24.18%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y60.53%
Revenue 1Y (TTM)-100%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.67%
EBIT Next 3Y42.97%
EBIT Next 5Y66.14%
FCF growth 1Y-217.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.51%
OCF growth 3YN/A
OCF growth 5YN/A

IPERIONX LTD - ADR / IPX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IPERIONX LTD - ADR (IPX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IPX.


What is the valuation status of IPERIONX LTD - ADR (IPX) stock?

ChartMill assigns a valuation rating of 1 / 10 to IPERIONX LTD - ADR (IPX). This can be considered as Overvalued.


What is the profitability of IPX stock?

IPERIONX LTD - ADR (IPX) has a profitability rating of 0 / 10.


Can you provide the financial health for IPX stock?

The financial health rating of IPERIONX LTD - ADR (IPX) is 5 / 10.


What is the earnings growth outlook for IPERIONX LTD - ADR?

The Earnings per Share (EPS) of IPERIONX LTD - ADR (IPX) is expected to decline by -24.18% in the next year.